Male Infertility

Global Male Infertility Market to Reach US$6.5 Billion by 2030

The global market for Male Infertility estimated at US$4.4 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. DNA Fragmentation Technique, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Oxidative Stress Analysis segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.6% CAGR

The Male Infertility market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Male Infertility Market - Key Trends and Drivers Summarized

Why Is Male Infertility Becoming a Major Focus in Reproductive Health?

Male infertility is an increasingly recognized issue in reproductive health, with studies indicating that male factors contribute to about 40% of infertility cases globally. Causes range from hormonal imbalances and genetic disorders to lifestyle factors such as smoking, obesity, and environmental exposures. Advances in diagnostic tools, including semen analysis, hormone profiling, and genetic testing, are helping to identify underlying causes of male infertility. Treatment options such as assisted reproductive technologies (ART), hormone therapies, and surgical interventions are becoming more sophisticated, offering hope to couples struggling to conceive. Male infertility is no longer a taboo subject but an area of active research and clinical focus.

What Innovations Are Shaping the Male Infertility Market?

The male infertility market is being shaped by innovations in diagnostics and treatment, particularly in areas such as genetic screening, sperm retrieval techniques, and ART. Advances in genetic testing are allowing for the identification of specific chromosomal abnormalities and gene mutations that may contribute to infertility, providing more personalized treatment options. New technologies such as testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) have revolutionized fertility treatments by allowing couples to conceive even when sperm count is extremely low. In addition, emerging treatments like stem cell therapy and gene editing hold promise for addressing the root causes of infertility, potentially offering long-term solutions.

How Do Market Segments Define the Growth of the Male Infertility Market?

Diagnostic methods include semen analysis, hormone testing, genetic testing, and imaging, with semen analysis being the most commonly used. Treatments range from lifestyle interventions and medication to surgical procedures and ART, with ART dominating the market due to its high success rates. Geographically, North America and Europe lead the market due to the availability of advanced fertility treatments and growing awareness of male infertility. However, the Asia-Pacific region is emerging as a significant growth area, driven by rising awareness and increasing access to fertility services.

What Factors Are Driving the Growth in the Male Infertility Market?

The growth in the male infertility market is driven by several factors, including increasing awareness of male reproductive health, advancements in diagnostic and treatment technologies, and lifestyle changes affecting male fertility. As societal norms evolve and infertility becomes less stigmatized, more men are seeking medical advice and treatment for fertility issues. Innovations in ART and genetic testing are providing more effective solutions, while the growing prevalence of lifestyle-related factors such as obesity, stress, and exposure to environmental toxins is contributing to a rise in male infertility cases. Additionally, the increasing number of fertility clinics and treatment options worldwide is making it easier for couples to access specialized care.

 

Select Competitors (Total 32 Featured) -

• Andrology Solutions
• Bayer AG
• Cadila Pharmaceuticals Ltd.
• Endo Pharmaceuticals Inc.
• Halotech DNA
• Intas Pharmaceuticals Ltd.
• Merck KGaA
• Sanofi
• SCSA Diagnostics, Inc.
• Vitrolife

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.